Literature DB >> 19465003

Angiotensin II induces type I collagen gene expression in human dermal fibroblasts through an AP-1/TGF-beta1-dependent pathway.

Hong-Tai Tang1, Da-Sheng Cheng, Yi-Tao Jia, Dao-Feng Ben, Bing Ma, Kai-Yang Lv, Duo Wei, Zhi-Yong Sheng, Zhao-Fan Xia.   

Abstract

Angiotensin II is critically involved in skin wound healing, but the underlying mechanism remains unclear. This study investigated the effect of angiotensin II on type I collagen gene activation in human dermal fibroblasts and the possible mechanism involved. Angiotensin II stimulated the mRNA and protein expression of type I collagen and TGF-beta1. Effects were abolished by the angiotensin AT1 receptor antagonist ZD7155 but not by the AT2 blocker PD123319. Blockade of TGF-beta1 markedly inhibited angiotensin II-induced type I collagen gene expression. Activator protein-1 (AP-1) decoy ODNs transfection suppressed angiotensin II-induced TGF-beta1 expression, and also, diminished type I collagen expression. These data indicated that angiotensin II induces collagen gene activation in human dermal fibroblasts through an AT1-mediated AP-1/TGF-beta1 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465003     DOI: 10.1016/j.bbrc.2009.05.081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Detection of Angiotensin II and AT1 Receptor Concentrations in Keloid and Hypertrophic Scar.

Authors:  Feizollah Niazi; Seyed Hassan Hooshyar; Keshvad Hedayatyanfard; Seyed Ali Ziai; Farideh Doroodgar; Sana Niazi; Behnam Habibi; Ali Asadirad
Journal:  J Clin Aesthet Dermatol       Date:  2018-10-01

2.  Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-β-activated kinase 1 (TAK1) pathways in mice.

Authors:  Wei-Qiang Tan; Qing-Qing Fang; Xiao Z Shen; Jorge F Giani; Tuantuan V Zhao; Peng Shi; Li-Yun Zhang; Zakir Khan; You Li; Liang Li; Ji-Hua Xu; Ellen A Bernstein; Kenneth E Bernstein
Journal:  Br J Pharmacol       Date:  2018-10-08       Impact factor: 8.739

Review 3.  NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers.

Authors:  Kathleen E Rodgers; Laura L Bolton; Shelagh Verco; Gere S diZerega
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-06-01       Impact factor: 4.730

Review 4.  Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).

Authors:  Kathleen Rodgers; Shelagh Verco; Laura Bolton; Gere Dizerega
Journal:  Expert Opin Investig Drugs       Date:  2011-10-06       Impact factor: 6.206

5.  The effects of Losartan on abdominal wall fascial healing.

Authors:  C N Criss; Y Gao; G De Silva; J Yang; J M Anderson; Y W Novitsky; H Soltanian; M J Rosen
Journal:  Hernia       Date:  2014-04-13       Impact factor: 4.739

6.  Enalapril stimulates collagen biosynthesis through prolidase-dependent mechanism in cultured fibroblasts.

Authors:  Lukasz Szoka; Ewa Karna; Renata Pawlak Morka; Jerzy A Palka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-03-17       Impact factor: 3.000

7.  Modulation of angiotensin II signaling in the prevention of fibrosis.

Authors:  Amanda M Murphy; Alison L Wong; Michael Bezuhly
Journal:  Fibrogenesis Tissue Repair       Date:  2015-04-23

8.  The Renal Protective Effect of Jiangya Tongluo Formula, through Regulation of Adrenomedullin and Angiotensin II, in Rats with Hypertensive Nephrosclerosis.

Authors:  Lin Han; Yan Ma; Jian-Guo Qin; Li-Na Li; Yu-Shan Gao; Xiao-Yu Zhang; Yi Guo; Lin-Mei Song; Yan-Ni Luo; Xiao-Yi Chi
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-18       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.